Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown
February 09, 2015 at 11:46 AM EST
AbbVie Inc(NYSE: ABBV) shares are likely to rally with the expected near-term release of new data on two key drug candidates, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.